Pharmaceutical Industry

Home
Sectors
Pharmaceutical Industry

17 April 2026

Humanis Accelerates Global Expansion: After China, the Next Target Is the U.S. Market

Humanis, the first Turkish company to export pharmaceuticals to China, is strengthening its global presence with a robust R&D infrastructure and a sustainability-driven growth strategy. The company has now set its sights on entering the U.S. market within the next 5 years, marking a critical milestone in its international expansion journey.

10 April 2026

The Key to Longevity Lies in Vascular Health: “It’s Not Age, It’s Vascular Age”

Longevity is determined not by chronological age, but by vascular health. According to Prof. Dr. Kerim Güler, when risk factors such as diabetes, obesity, and hypertension coexist, health risks can increase by up to 60 times. Experts emphasize the importance of early intervention and lifestyle management.

03 April 2026

World Medicine Maintains Leadership in Pharmaceutical Exports: 5th Consecutive Win

According to the “Stars of Export 2025” awards by İKMİB, World Medicine once again ranked first in pharmaceutical exports, reinforcing its global strength.

30 March 2026

Philips Tops European Patent Rankings in Medtech, Secures No.1 Position at EPO

Royal Philips has ranked No.1 among medical technology companies in the European Patent Office’s (EPO) 2025 Technology Dashboard. The company filed 676 medtech patent applications in 2025 alone. AI-driven innovation continues to power its strong pipeline in health technology.

30 March 2026

Eli Lilly Expands AI Drug Discovery Alliance with Insilico in Deal Worth Up to $2.75 Billion

Eli Lilly is deepening its push into AI-driven drug discovery through an expanded partnership with Insilico Medicine. The deal, valued at up to $2.75 billion, targets the development of novel oral therapies currently in preclinical stages. The collaboration aims to accelerate multi-disease targeting through advanced AI models.

18 March 2026

Executive Appointment at Italfarmaco Türkiye: Selim Özyılmaz Named General Manager Subheadline

Selim Özyılmaz has been appointed as General Manager of Italfarmaco Türkiye (ITF Pharma).

12 March 2026

Santa Farma Passes DIGEMID GMP Inspection in Peru

Turkish pharmaceutical manufacturer Santa Farma has successfully passed a major international regulatory inspection. The company’s GEBKİM Dilovası production facility completed the GMP (Good Manufacturing Practices) audit conducted by Peru’s health authority DIGEMID with a positive assessment. The certification further strengthens Santa Farma’s regulatory standing and market access in Latin America.

12 March 2026

Dr. Sabri Öncel Appointed as New CEO

One of Türkiye’s long-established pharmaceutical companies, Drogsan Pharmaceuticals, has announced a significant leadership transition. Dr. Sabri Öncel has been appointed as the company’s new Chief Executive Officer, effective March 9, 2026. Former CEO Dr. Ersan Küçük, who led the company for 18 years, will continue contributing as a strategic advisor.

09 March 2026

Senior Appointment at AIFD: Dr. Nihan Burul Bozkurt Named Deputy Secretary General

The Association of Research-Based Pharmaceutical Companies (AIFD) has announced a key leadership appointment. Dr. Pharmacist Nihan Burul Bozkurt, who has served as Director of Health Policies since 2021, has been promoted to Deputy Secretary General of the association. In her new role, she will lead strategic health policy initiatives and manage AIFD’s relations with major global pharmaceutical organizations.

05 March 2026

Humanis Introduces New Treatment for Parkinson’s Disease Psychosis in Türkiye

Psychotic symptoms such as hallucinations and delusions may emerge as Parkinson’s disease progresses, significantly affecting patients’ quality of life. The new treatment introduced by Humanis in Türkiye aims to expand the limited therapeutic options available for Parkinson’s disease psychosis and improve outcomes for both patients and caregivers

03 March 2026

Orzax Marks World Omega-3 Day with “Blue Trace” Initiative to Combat Ghost Nets

Orzax has launched a comprehensive initiative against ghost nets threatening marine ecosystems under its “Blue Trace” project, announced as part of World Omega-3 Day on March 3. Ghost nets recovered from the seabed by professional divers have been repurposed through art to raise environmental awareness. The initiative represents a key pillar of the company’s long-term commitment to protecting marine biomass.

19 February 2026

Santa Farma Reaches a New Milestone in Its Global Journey with TURQUALITY Support Program

Santa Farma, one of Türkiye’s long-established pharmaceutical companies, has been included in the TURQUALITY Support Program, aiming to further strengthen its competitiveness in international markets.

‹ 1 2 3 4 5 ›

Common Screen Cleaning Myths You Need to Stop Believing

2026 Nobel Prize in Chemistry Awarded to Henri B. Kagan and Kenso Soai

Silverson and Holiferm Collaborate on Bio-Based Toothpaste Formulation

Eti Bakır Publishes Climate and Nature Assessment Report

AKO Group Extends Commercial Tire Lifespans via Retreading

Atelier Rebul Expands Its Signature Istanbul Collection with New Shower Foam

FUCHS and Mercedes-Benz Extend Long-Standing Strategic Partnership

Azerbaijan’s Largest Pharmaceutical Plant Commences Operations with Turkish Investment

Advertise with ChemEx World